We present a case of endometrioid carcinoma metastasis in the bladder mimicking as the second primary of urinary bladder on 18 F-fluorodeoxyglucose positron-emission tomography/computed tomography ( 18 F-FDG PET/CT). The presentations of bladder lesions on 18 F-FDG PET/CT are varied, and rare presentations of common malignancies can pose a significant diagnostic challenge as in the index case and highlight the importance of histopathological examination to confirm any unusual FDG uptake confounding the diagnosis. Figure 1d and e]. Intense tracer uptake was also noted in few enlarged peripancreatic, mesenteric, precaval, aortocaval, retrocaval, and bilateral external iliac lymph nodes. With a provisional diagnosis of second malignancy in the urinary bladder, the patient underwent transurethral resection of bladder tumor (TURBT). However, histopathology revealed the presence of metastatic endometrioid adenocarcinoma [ Figure 2a and b].
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Endometrial carcinoma is a common malignancy of female genital tract with an increasing incidence in the postmenopausal women. [1, 2] Local recurrence and distant metastases from advanced endometrial carcinoma, even after surgical resection, are known to occur in the pelvis, pelvic and paraaortic lymph nodes, peritoneum, and lungs. Supradiaphragmatic lymph nodes, liver, adrenals, brain, and soft tissues are the uncommon sites for metastases. [3] In advanced cases, it may rarely involve the bladder and bowel mucosa also.
[4] Urinary bladder involvement in endometroid carcinoma is a rare entity resulting from direct extension, metastasis, or malignant transformation of endometriosis. [3, 4] This case showcased a diagnostic conundrum of an endometrial neoplasm metastatic to the bladder giving an initial impression of a second primary urothelial malignancy on imaging.
F-FDG PET/CT is a very sensitive oncological imaging modality
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with ever-increasing role in genitourinary malignancies. The unusual presentations have been recognized with improved imaging. Few of imaging limitations and pitfalls are encountered, and some of them had been addressed. [5] [6] [7] However, in the index case, subsequent TURBT and histopathological examination revealed the features of nonurological endometroid adenocarcinoma. Thus, this case emphasizes the diagnostic challenges posed by rare presentations of certain malignancies on 18 F-FDG PET/CT and the importance of histopathological examination to ascertain the accurate diagnosis and management in such cases.
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